# Clinical Prognosis and Progression of Myasthenia Gravis Patients

> **NCT04101578** · — · UNKNOWN · sponsor: **Da, Yuwei, M.D.** · enrollment: 2000 (estimated)

## Conditions studied

- Myasthenia Gravis

## Interventions

- **DRUG:** Symptomatic Treatment, Steroids, Immunosuppressive Agents, Plasma Exchange(PE), Intravenous Immunoglobulin(IVIg)

## Key facts

- **NCT ID:** NCT04101578
- **Lead sponsor:** Da, Yuwei, M.D.
- **Sponsor class:** INDIV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-02-08
- **Primary completion:** 2023-06-01
- **Final completion:** 2024-12-31
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2021-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04101578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04101578, "Clinical Prognosis and Progression of Myasthenia Gravis Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04101578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*